Fulvio Massaro

1.6k total citations
52 papers, 921 citations indexed

About

Fulvio Massaro is a scholar working on Hematology, Genetics and Neurology. According to data from OpenAlex, Fulvio Massaro has authored 52 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 17 papers in Genetics and 17 papers in Neurology. Recurrent topics in Fulvio Massaro's work include Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Fulvio Massaro is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Fulvio Massaro collaborates with scholars based in Italy, Belgium and France. Fulvio Massaro's co-authors include Michele Lanotte, Matteo Molica, Massimo Breccia, G. Faccani, Beth Ketcik, Jiping He, Giancarlo Barolat, S. Zeme, P. Ciaramitaro and Gioia Colafigli and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Journal of neurosurgery.

In The Last Decade

Fulvio Massaro

47 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fulvio Massaro Italy 17 261 233 161 158 145 52 921
J Brunon France 14 296 1.1× 238 1.0× 100 0.6× 16 0.1× 116 0.8× 69 813
Jacob H. Bagley United States 10 271 1.0× 151 0.6× 32 0.2× 9 0.1× 56 0.4× 22 600
Michael Möllmann Germany 17 64 0.2× 315 1.4× 104 0.6× 142 0.9× 136 0.9× 66 875
Sharad Rajpal United States 18 116 0.4× 676 2.9× 45 0.3× 25 0.2× 18 0.1× 50 1.2k
Αναστασία Τάσιου Greece 19 337 1.3× 272 1.2× 17 0.1× 63 0.4× 55 0.4× 38 957
Tae Hyung Han United States 14 49 0.2× 156 0.7× 102 0.6× 41 0.3× 82 0.6× 47 872
Talat Kırış Türkiye 20 633 2.4× 423 1.8× 8 0.0× 48 0.3× 186 1.3× 48 1.3k
Francesco Meli Italy 18 220 0.8× 172 0.7× 5 0.0× 191 1.2× 166 1.1× 46 836
Chunde Li China 15 146 0.6× 186 0.8× 8 0.0× 58 0.4× 327 2.3× 91 888
L. Pellegrini France 7 140 0.5× 78 0.3× 44 0.3× 77 0.5× 72 0.5× 14 518

Countries citing papers authored by Fulvio Massaro

Since Specialization
Citations

This map shows the geographic impact of Fulvio Massaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvio Massaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvio Massaro more than expected).

Fields of papers citing papers by Fulvio Massaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fulvio Massaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvio Massaro. The network helps show where Fulvio Massaro may publish in the future.

Co-authorship network of co-authors of Fulvio Massaro

This figure shows the co-authorship network connecting the top 25 collaborators of Fulvio Massaro. A scholar is included among the top collaborators of Fulvio Massaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulvio Massaro. Fulvio Massaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messineo, Daniela, Fulvio Massaro, Alessandro Milani, et al.. (2024). Radiomic application for head and neck squamocellular tumor: systematic review. IRIS Research product catalog (Sapienza University of Rome).
2.
3.
Massaro, Fulvio, et al.. (2024). Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders. Biomedicines. 12(5). 977–977. 2 indexed citations
4.
Ciaramitaro, P., Giuseppe Migliaretti, Giovanni Morana, et al.. (2023). Syringomyelia Associated with Chiari 1 Malformation in Adults: Positive Outcome Predictors after Posterior Fossa Decompression with Duraplasty. Journal of Clinical Medicine. 12(8). 3019–3019. 7 indexed citations
5.
Massaro, Fulvio, et al.. (2023). Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression. Frontiers in Immunology. 14. 1267550–1267550. 20 indexed citations
6.
7.
Besutti, Giulia, Fulvio Massaro, Luca Braglia, et al.. (2021). Prognostic Impact of Muscle Quantity and Quality and Fat Distribution in Diffuse Large B-Cell Lymphoma Patients. Frontiers in Nutrition. 8. 620696–620696. 22 indexed citations
8.
Zanelli, Magda, Maurizio Zizzo, Alessandra Bisagni, et al.. (2020). Germinotropic lymphoproliferative disorder: a systematic review. Annals of Hematology. 99(10). 2243–2253. 21 indexed citations
9.
Carmosino, Ida, Massimo Breccia, Sara Mohamed, et al.. (2019). Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib. Oncology Research and Treatment. 42(12). 660–664. 3 indexed citations
10.
Ciaramitaro, P., et al.. (2019). Clinical diagnosis—part I: what is really caused by Chiari I. Child s Nervous System. 35(10). 1673–1679. 16 indexed citations
11.
Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2018). Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?. European Journal Of Haematology. 101(5). 578–584. 1 indexed citations
12.
Massaro, Fulvio, Matteo Molica, & Massimo Breccia. (2017). Ponatinib: A Review of Efficacy and Safety. Current Cancer Drug Targets. 18(9). 847–856. 62 indexed citations
13.
Perrone, Salvatore, Fulvio Massaro, Giuliana Alimena, & Massimo Breccia. (2016). How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety. Expert Opinion on Pharmacotherapy. 17(11). 1517–1526. 3 indexed citations
14.
Massaro, Fulvio, Matteo Molica, & Massimo Breccia. (2016). How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changes. Expert Review of Hematology. 10(2). 155–159. 8 indexed citations
15.
Bruno, Antonio, et al.. (2006). Somatosensory- and motor-evoked potential monitoring during spine and spinal cord surgery. Spinal Cord. 45(1). 86–91. 66 indexed citations
16.
D’Avella, Domenico, Franco Servadei, Massimo Scerrati, et al.. (2003). Traumatic acute subdural haematomas of the posterior fossa: clinicoradiological analysis of 24 patients. Acta Neurochirurgica. 145(12). 1037–1044. 17 indexed citations
17.
Massaro, Fulvio, et al.. (1996). One hundred and twenty-seven cases of acute subdural haematoma operated on. Acta Neurochirurgica. 138(2). 185–191. 107 indexed citations
18.
19.
Barolat, Giancarlo, Fulvio Massaro, Jiping He, S. Zeme, & Beth Ketcik. (1993). Mapping of sensory responses to epidural stimulation of the intraspinal neural structures in man. Journal of neurosurgery. 78(2). 233–239. 175 indexed citations
20.
Pagni, C. A. & Fulvio Massaro. (1991). Concomitant cranio-cerebral and vertebro-medullary injuries. Analysis of 121 cases. Acta Neurochirurgica. 111(1-2). 1–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Brunon Breakdown of academic impact, for papers by Jacob H. Bagley Breakdown of academic impact, for papers by Michael Möllmann Breakdown of academic impact, for papers by Sharad Rajpal Breakdown of academic impact, for papers by Αναστασία Τάσιου Breakdown of academic impact, for papers by Tae Hyung Han Breakdown of academic impact, for papers by Talat Kırış Breakdown of academic impact, for papers by Francesco Meli Breakdown of academic impact, for papers by Chunde Li Breakdown of academic impact, for papers by L. Pellegrini
Rankless by CCL
2026